Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to 11.17%.

  • Sanara MedTech's EBIT Margin rose 75800.0% to 11.17% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.79%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 7.75% for FY2024, which is 12600.0% down from last year.
  • According to the latest figures from Q3 2025, Sanara MedTech's EBIT Margin is 11.17%, which was up 75800.0% from 0.12% recorded in Q2 2025.
  • Sanara MedTech's 5-year EBIT Margin high stood at 11.17% for Q3 2025, and its period low was 48.52% during Q4 2021.
  • Moreover, its 5-year median value for EBIT Margin was 14.31% (2024), whereas its average is 15.75%.
  • Per our database at Business Quant, Sanara MedTech's EBIT Margin tumbled by -307300bps in 2021 and then soared by 281300bps in 2022.
  • Over the past 5 years, Sanara MedTech's EBIT Margin (Quarter) stood at 48.52% in 2021, then skyrocketed by 58bps to 20.39% in 2022, then soared by 94bps to 1.28% in 2023, then plummeted by -1600bps to 21.72% in 2024, then surged by 151bps to 11.17% in 2025.
  • Its last three reported values are 11.17% in Q3 2025, 0.12% for Q2 2025, and 8.88% during Q1 2025.